2019 as well as having the enhancing cost control measures. The details of the Company's performance were as follows: 2018 2019 YoY Mio. % Mio. % Mio. % Rental and Service Income 534.1 58.3% 465.9 50.2

, with 0.18 million baht decrease with no significantly transaction changes. 2. Cost of sale , Profit margin For Quarter 1 of the year 2020, the company had cost of sale of 98.36 million bath compare to

million or 7%, mainly due to an increase in cost of real estate sold which varied with an increase in revenue from sales of real estate. Page 3 of 4 IV Expense (Unit: Million Baht) Second quarter 6-month

Floor, Silom Road, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th 3-Month Period Ending March 31st 2020 2019 Change MB % MB % MB % Cost of Sales 35.76

. ** Recoverable amount as at the agreement date is calculated on the project value by cost approach at the shareholding proportion 80%. Basis used in Value Measurement The price negotiation between the buyer and

equipment for lease 80.9 80.6 55.2 0.3 0.4 25.7 46.6 Cost of sales and service 1,348.2 953.9 1,366.0 394.3 41.3 (17.8) (1.3) Cost of equipment for lease 44.2 42.6 31.3 1.6 3.8 12.9 41.2 Administrative

-85.8 1,760 6,093 -71.1 Finance cost 473 324 46.0 852 628 35.7 Interest expense from the MRT Purple Line Project * 75 97 -22.7 151 196 -23.0 Profit before income tax expenses 123 4,311 -97.1 757 5,269

cost following the widened average DTD/DB spread. Further, crude oil price significantly drop during the year end, led to the refinery business to record Inventory Loss of THB 1,489 million Management

cost due to the oil price, Long-term lease payments which have been adjusted to some financial costs and adjusting the employee benefit estimate. Please be informed accordingly. Yours sincerely, Waewta

or 70.6%, resulted from increasing of pork price from Q2/2018 and past services cost for long-term employee benefit expenses. Page 3/…… - 3 - Financial Position Assets As of June 30, 2019 the company